Señales en vivo de RVMD | Maximiza tus Ganancias con Getagraph.com

VENDER 778 min ago

@ $37.92

Emitido: 1 may 2024 @ 13:36

Retorno: 2.36%

Señal anterior: may 1 - 13:06

Señal anterior: Comprar

Retorno: 1.48 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.72% compare to its pairs and should correct upwards.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers...

Stats
Volumen de hoy	1.41M
Volumen promedio	1.50M
Capitalización de mercado	6.62B
EPS	$0 ( 2024-02-26 )
Próxima fecha de ganancias	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.06
ATR14	$2.36 (6.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Goldsmith Mark A	Sell	7 500	Common Stock
2024-04-10	Goldsmith Mark A	Sell	5 000	Common Stock
2024-04-10	Goldsmith Mark A	Sell	5 000	Common Stock
2024-04-10	Patel Sushil	Sell	2 155	Stock Option (Right to Buy)
2024-04-10	Patel Sushil	Buy	2 155	Common Stock

INSIDER POWER
73.02
Last 99 transactions
Buy: 5 403 428 \| Sell: 788 601

Correlación (AI algo v.1.1b): Undervalued: 0.72% $39.13 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: 0.72 (moderate)

Corto: -0.93 (very strong negative)

Signal:(43) Neutral

Revolution Medicines Inc Correlación

10 Correlaciones Más Positivas
TBNK	0.884
RING	0.853
RGLD	0.852
DOOO	0.849
GTH	0.834
GRAB	0.834
TRUE	0.831
PWOD	0.83
MCHI	0.828
YY	0.825

10 Correlaciones Más Negativas
LLNW	-0.82
SFET	-0.808
LNSR	-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Revolution Medicines Inc Correlación - Moneda/Commodity

0.21
( neutral )

0.09
( neutral )

0.89
( strong )

0.46
( neutral )

-0.44
( neutral )

Revolution Medicines Inc Finanzas

Annual	2023
Ingresos:	$11.58M
Beneficio Bruto:	$2.27M (19.61 %)
EPS:	$-3.86

FY	2023
Ingresos:	$11.58M
Beneficio Bruto:	$2.27M (19.61 %)
EPS:	$-3.86

FY	2022
Ingresos:	$35.38M
Beneficio Bruto:	$25.72M (72.71 %)
EPS:	$-3.08

FY	2021
Ingresos:	$29.39M
Beneficio Bruto:	$29.39M (100.00 %)
EPS:	$-2.57

Financial Reports:

No articles found.

Revolution Medicines Inc

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Actualizaciones en tiempo real para Revolution Medicines Inc [RVMD]

Upcoming Earnings Alert